Skip to main content
. 2016 Jun 30;2016:2565169. doi: 10.1155/2016/2565169

Table 2.

Clinical indexes during treatment.

Shenfu Controls P value
48 h n = 102 n = 97
Blood glucose (mmol/L) 9.01 ± 6.33 7.81 ± 3.07 0.134
PT (s) 14.20 ± 3.63 14.39 ± 7.51 0.858
APTT (s) 37.28 ± 9.00 36.76 ± 9.81 0.749
Fibrinogen (g/dL) 3.76 ± 1.64 4.60 ± 6.12 0.304
BUN 10.44 ± 7.86 9.28 ± 7.10 0.346
Cr 101.16 ± 71.98 104.94 ± 94.68 0.784
ALT 78.51 ± 140.56 54.96 ± 54.54 0.165
AST 102.29 ± 161.02 74.46 ± 91.01 0.235
WBC 13.33 ± 9.61 12.06 ± 10.22 0.422
RBC 3.40 ± 0.68 3.75 ± 1.01 0.012
HCT 30.66 ± 6.28 31.71 ± 7.31 0.331
Platelets (×109/L) 108.49 ± 75.42 115.31 ± 81.19 0.585

48 h n = 15 n = 10
CVP (cmH2O) 10.67 ± 4.46 6.35 ± 3.16 0.018
ScvO2 79.63 ± 13.28 54.70 ± 28.81 0.017

6 d n = 102 n = 97
Arterial lactate (mmol/L) 2.37 ± 2.81 2.60 ± 2.52 0.533
Lactate clearance −0.40 ± 0.59 −0.33 ± 0.39 0.369

24 h n = 102 n = 97
APACHE 2 14.75 ± 9.13 15.14 ± 11.22 0.846

5 d n = 102 n = 97
Urine output (mL/h) 91.91 ± 49.97 102.18 ± 40.25 0.274

6 d n = 57 n = 50
Systolic pressure (mmHg) 33.88 ± 19.44 34.72 ± 25.97 0.851
Diastolic pressure (mmHg) 15.46 ± 16.25 13.12 ± 16.52 0.463
MAP (mmHg) 21.60 ± 15.82 20.32 ± 18.26 0.699
Heart rate (bpm) −24.51 ± 21.78 −26.20 ± 26.74 0.719
Dose of dopamine (mg) 842.04 ± 835.81 1224.71 ± 1704.24 0.237
Number of dopamine uses n = 29 n = 37 0.229
Dose of norepinephrine (mg) 72.67 ± 64.19 80.59 ± 137.68 0.759
Number of epinephrine uses n = 36 n = 35 0.99
ICU day (day) 9.4 ± 11.3 9.1 ± 14.4 0.895
Total hospital day (day) 15.2 ± 13.7 14.1 ± 15.8 0.675

PT: prothrombin time; aPTT: activated partial prothrombin time; BUN: blood urea nitrogen; Cr: creatinine; ALT: alanine transaminase; AST: aspartate transaminase; WBC: white blood cells; RBC: red blood cells; HCT: hematocrit; CVP: central venous pressure; ScvO2: central venous oxygen saturation; APACHE: acute physiology and chronic health evaluation; ICU: intensive care unit.